Peter Emtage

Title: The Innovations of Peter Emtage

Introduction

Peter Emtage is a notable inventor based in San Francisco, CA. He has made significant contributions to the field of biotechnology, particularly in cancer treatment. His work focuses on the development of innovative therapeutic proteins that can enhance immune responses against tumors.

Latest Patents

Peter Emtage holds a patent for "CD40L-Fc fusion polypeptides and methods of use thereof." This patent describes a CD40L-Fc fusion protein and outlines methods for using this fusion protein in cancer treatment. The approach involves administering the CD40L-Fc fusion protein alone or in combination with immune checkpoint inhibitors, such as anti-CTLA4 and anti-PD-L1 antibodies. He has 1 patent to his name.

Career Highlights

Emtage has built a successful career in the biotechnology sector. He is currently associated with MedImmune Limited, where he continues to work on groundbreaking research and development projects. His expertise in immunology and protein engineering has positioned him as a key figure in the fight against cancer.

Collaborations

Peter Emtage collaborates with talented professionals in his field, including colleagues Manuel Baca and Stacey Drabic. These collaborations enhance the innovative potential of his research and contribute to the advancement of cancer therapies.

Conclusion

Peter Emtage's work exemplifies the impact of innovative thinking in biotechnology. His contributions to cancer treatment through the development of CD40L-Fc fusion proteins highlight the importance of research and collaboration in advancing medical science.